Screening prostate cancer incidence
It has the potential to reduce false negatives and speed up diagnosis, which can make a life-saving difference to patients.
Prostate biopsy, the most reliable method of detection, is a challenge because of the difficulties in visualizing not only the entirety of the prostate, but also the location of the biopsy needle.
Trans-rectal ultrasound-guided prostate biopsy TRUSthe current biopsy standard, commonly suffers from poor image resolution, and the biopsy needle often passes through tumor-free areas of the prostate — potentially missing the tumor entirely.
UroNav — image-guided prostate biopsies UroNav is an image-guided stereotactic biopsy system used to detect prostate cancer within patients as an alternative to current blind or blind systematic biopsies. It uses multi- parametric magnetic resonance mpMR imaging, fused with live ultrasound US guidance in conjunction with electromagnetic EM tracking to plan, guide, and document prostate biopsies.
UroNav simultaneously displays registered MR and ultrasound images and the projected needle path relative to the suspicious target lesion during the tratamentul prostatitei în rusia procedure and guides the urologist in real-time.
Earlier diagnosis —the pathway to better outcomes This novel approach has the ability to improve the sensitivity and specificity of prostate biopsies.
This results in a reduced incidence rate of false negative biopsy results. By enabling earlier diagnosis, UroNav allows a broader array of treatment options screening prostate cancer incidence be considered by the clinician, less complications for the patient, and a more cost-effective resolution for the care provider. From set up to post-biopsy review, UroNav guides you through its intuitive workflow.
After a quick initialization of the navigation system upper imageUroNav creates a 3D ultrasound volume from a standard 2D scan of the prostate lower image. Clinical studies Clinical studies are being carried out by clinical partners, including Dr. For more information Access clinical studies about UroNav.